Professional Documents
Culture Documents
Adverse Effect Ampicillin
Adverse Effect Ampicillin
Frequency not reported: Erythematous maculopapular rash (including mildly pruritic), macular
rash, purpura, maculopapular rash, skin reactions (e.g., erythema multiforme, Stevens-Johnson
syndrome, toxic epidermal necrolysis), other skin rashes, erythematous eruptions, acute
generalized exanthematous pustulosis[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea, nausea, vomiting, flatulence/meteorism, soft
stools, abdominal pain
Acute pancreatitis has been reported and confirmed by rechallenge with this drug in a patient in
whom there was no other obvious cause of pancreatitis.[Ref]
Local
Common (1% to 10%): Localized phlebitis
Other
Common (1% to 10%): Swelling and pain, exanthema and enanthem in the oral region
Hypersensitivity
Uncommon (0.1% to 1%): Serious allergic reactions (e.g., serum sickness, allergic nephritis)
Frequency not reported: Prolonged activated partial thromboplastin time, platelet aggregation
abnormalities, neutropenia, Henoch Schonlein purpura, red cell aplasia[Ref]
Neutropenia was described in a case report of 3 pediatric patients who received high doses (150
to 400 mg/kg) of this drug IV. In all 3 cases, white blood cell and neutrophil counts returned to
normal after discontinuation of therapy.[Ref]
Nervous system
Rare (0.01% to 0.1%): Headache, dizziness, myoclonus, seizures
Seizures have been reported with renal dysfunction or at very high IV doses.
Seizures have been reported in patients with high serum drug levels, although these patients were
otherwise very ill. High cerebral spinal fluid (CSF) levels of some penicillins were known to be
potentially neurotoxic, and the CSF level of this drug increased significantly in meningitis.
Generalized seizures have been described in 2 patients during use of this drug, although in both
cases, there were underlying disease factors that may have predisposed the patients to seizure
activity.
Encephalopathy has occurred when blood drug level reached 800 mg/L.
Toxic symptoms (e.g., drowsiness, hyperreflexia, myoclonic twitches, convulsions, coma) have
occurred at lower drug levels in patients with meningitis; the blood-brain barrier became more
permeable in meningitis.[Ref]
Renal
Uncommon (0.1% to 1%): Acute interstitial nephritis
Very rare (less than 0.01%): Acute renal failure with excretion of urine crystals
Hepatic
Mild, temporary elevation in AST reported in patients who received larger (2 to 4 times) and more
frequent IM injections than usual. Evidence indicated AST was released at IM injection sites for
this drug and increased AST did not necessarily indicate liver involvement.[Ref]
Genitourinary
Crystalluria has been reported with high-dose IV administration.[Ref]
Respiratory
Uncommon (0.1% to 1%): Laryngeal edema
Musculoskeletal
Frequency not reported: Arthralgia
Metabolic
Frequency not reported: Anorexia